NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 856000000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2020-09-30)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2021-09-30
Retrieved: 2026-08-24T00:24:40.043860+02:00
Raw response sha256: acbf44e2b606ae58541d38e9d1350948…
Cite as: FACTANKER, https://factanker.com/fact/25fcd7fc-bf50-4b88-b1e5-9a7c4088936f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies